Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yoshinao Muro, Kazumitsu Sugiura & Masashi Akiyama. (2013) Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 46:4, pages 279-284.
Read now
Read now
Aurora Menéndez, Jesús Gómez, Esther Escanlar, Luis Caminal-Montero & Lourdes Mozo. (2013) Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection. Autoimmunity 46:1, pages 32-39.
Read now
Read now
Articles from other publishers (138)
Sepehr Nayebirad, Aida Mohamadi, Hannaneh Yousefi-Koma, Minoo Javadi, Kimia Farahmand, Reza Atef-Yekta, Zahra Tamartash, Mana Jameie, Amir Mohammad Mohammadzadegan & Hoda Kavosi. (2023) Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis. BMJ Open Respiratory Research 10:1, pages e002076.
Crossref
Crossref
Tulaton Sodsri, Tananchai Petnak & Pintip Ngamjanyaporn. (2023) Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study. Journal of Clinical Medicine 12:21, pages 6849.
Crossref
Crossref
Viggo Hamberg, Azita Sohrabian, Elizabeth R. Volkmann, Marie Wildt, Anna Löfdahl, Dirk M. Wuttge, Roger Hesselstrand, Göran Dellgren, Gunilla Westergren-Thorsson, Johan Rönnelid & Kristofer Andréasson. (2023) Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study. Arthritis Research & Therapy 25:1.
Crossref
Crossref
Beatriz Lima Corrêa de Araújo, David R Victor, Heloísa Maria Farias Fontes, Rayana Maria Caminha Mendes Gomes & Leonardo Lima Corrêa de Araújo. (2023) Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report. Cureus.
Crossref
Crossref
Neha Narayan & Christopher T. Richardson. (2023) Serologic differences between dermatomyositis and antisynthetase syndrome using a commercially available autoantibody panel: A retrospective cohort study. Journal of the American Academy of Dermatology.
Crossref
Crossref
Robert W. Hallowell & Sonye K. Danoff. (2023) Diagnosis and Management of Myositis-Associated Lung Disease. Chest 163:6, pages 1476-1491.
Crossref
Crossref
Yin Zhao, Chen Zhang, Haiyuan Su, Xiaoyang Yin, Xinlei Liu, Hou Hou, Gaoya Wang, Dong Li, Na Zhang & Wei Wei. (2023) Predictive factors for progressive fibrosing interstitial lung disease in anti‐synthetase syndrome. International Journal of Rheumatic Diseases 26:5, pages 885-894.
Crossref
Crossref
Mamatha Gorijavolu, Devender Bairwa, Sachit Ganapathy, Saikumar Dunga, Aishwarya Gopal, Ramesh Ananthakrishnan, Molly Mary Thabah, Vir Singh Negi & Chengappa G Kavadichanda. (2023) Semi-quantitative thigh magnetic resonance imaging scores in assessing disease activity and determining long-term clinical outcome in idiopathic inflammatory myopathies: a causal mediation analysis. Rheumatology.
Crossref
Crossref
Ruoming Wang, Yin Zhao, Fumin Qi, Xiuhua Wu, Yingai Wang, Yong Xu, Yanan Wu, Na Zhang, Hou Hou, WenWen Sun, Xin Li & Wei Wei. (2022) Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China. Clinical Rheumatology 42:3, pages 703-709.
Crossref
Crossref
Chengyin Lv, Hanxiao You, Lingxiao Xu, Lei Wang, Fenghong Yuan, Ju Li, Min Wu, Shiliang Zhou, Zhanyun Da, Jie Qian, Hua Wei, Wei Yan, Lei Zhou, Yan Wang, Songlou Yin, Dongmei Zhou, Jian Wu, Yan Lu, Dinglei Su, Zhichun Liu, Lin Liu, Longxin Ma, Xiaoyan Xu, Yinshan Zang, Huijie Liu, Tianli Ren, Fang Wang, Miaojia Zhang & Wenfeng Tan. (2023) Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk. The Journal of Rheumatology 50:2, pages 219-226.
Crossref
Crossref
Yuji Hosono, Akira Ishii, Yuto Izumi, Noriko Sasaki, Shinichi Nogi, Chiho Yamada & Shinji Sato. (2023) New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody. Modern Rheumatology.
Crossref
Crossref
Chengna Lv, Qipan Zhang, Pan Tang, Lun Guo & Qunli Ding. (2022) Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases. Advances in Rheumatology 62:1.
Crossref
Crossref
Diego Armando Oquendo Gahona, Cindy Consuelo Romero Méndez & Julián Andrés Valverde Cortés. (2022) Organizing pneumonia due to anti-synthetase syndrome: Presentation of a clinical case. Revista Colombiana de Reumatología (English Edition) 29:4, pages 367-372.
Crossref
Crossref
Diego Armando Oquendo Gahona, Cindy Consuelo Romero Méndez & Julián Andrés Valverde Cortés. (2022) Organizing pneumonia due to anti-synthetase syndrome: Presentation of a clinical case. Revista Colombiana de Reumatología 29:4, pages 367-372.
Crossref
Crossref
Andrés Hormaza-Jaramillo, Vanessa Bedoya-Joaqui, Germán Puerta-Sarmiento, Mario Bautista, Lady J. Rios-Serna, Tatiana Delgado-Mora, Ivana Nieto-Aristizábal & Ingrid Ruiz-Ordoñez. (2022) Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population. Frontiers in Medicine 9.
Crossref
Crossref
Na Zhao, Wei Jiang, Hongliang Wu, Ping Wang, Xiaoni Wang, Yu Bai, Yao Li, Yanchun Tang & Ying Liu. (2022) Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease. Frontiers in Immunology 13.
Crossref
Crossref
Beenish Zulfiqar, Pavel Aksionav, Mohamad Bittar & Cathy Chapman. (2022) A Case of Anti-Jo-1 Myositis with Unique Biopsy Findings. Case Reports in Rheumatology 2022, pages 1-4.
Crossref
Crossref
Angeles S. Galindo-Feria, Antonella Notarnicola, Ingrid E. Lundberg & Begum Horuluoglu. (2022) Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond. Frontiers in Immunology 13.
Crossref
Crossref
Emilie Chalayer, Baptiste Gramont, Franck Zekre, Roman Goguyer-Deschaumes, Louis Waeckel, Lucile Grange, Stéphane Paul, Amy W. Chung & Martin Killian. (2022) Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmunity Reviews 21:3, pages 103016.
Crossref
Crossref
H. Shakshouk, M. A. Deschaine, D. A. Wetter, L. A. Drage, F. C. Ernste & J. S. Lehman. (2021) Clinical and histopathological features of adult patients with dermatomyositis and melanoma differentiation associated‐5 autoantibody seropositivity status, as determined by commercially available testing: a retrospective, single‐institution comparative cohort study. Clinical and Experimental Dermatology 47:2, pages 282-288.
Crossref
Crossref
Edward K. L. Chan. (2022) Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis. Clinical Reviews in Allergy & Immunology 63:2, pages 178-193.
Crossref
Crossref
Soran Peshbahar, Charlotte Hyldgaard & Elisabeth Bendstrup. (2022) Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation. Respiratory Medicine Case Reports 38, pages 101686.
Crossref
Crossref
Noriko Arase, Hideaki Tsuji, Hyota Takamatsu, Hui Jin, Hachiro Konaka, Yasuhito Hamaguchi, Kyoko Tonomura, Yorihisa Kotobuki, Ikuko Ueda-Hayakawa, Sumiko Matsuoka, Toru Hirano, Hideki Yorifuji, Hiroyuki Murota, Koichiro Ohmura, Ran Nakashima, Tomoharu Sato, Atsushi Kumanogoh, Ichiro Katayama, Hisashi Arase & Manabu Fujimoto. (2022) Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Journal of Autoimmunity 126, pages 102774.
Crossref
Crossref
Alexandra Nagy, Tamas Nagy, Abigel Margit Kolonics-Farkas, Noemi Eszes, Krisztina Vincze, Eniko Barczi, Adam Domonkos Tarnoki, David Laszlo Tarnoki, György Nagy, Emese Kiss, Pal Maurovich-Horvat, Aniko Bohacs & Veronika Müller. (2021) Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline. Frontiers in Pharmacology 12.
Crossref
Crossref
Udo Schneider, Werner Stenzel & Bruno Stuhlmüller. (2021) Biomarker und Histologie bei idiopathischen inflammatorischen Myopathien. Aktuelle Rheumatologie 46:04, pages 343-360.
Crossref
Crossref
Catalina I. Dumitrascu, David A. Olsen, Katherine W. Arendt, Carl H. Rose & Emily E. Sharpe. (2021) Antisynthetase Syndrome with Severe Interstitial Lung Disease in Pregnancy. Case Reports in Anesthesiology 2021, pages 1-4.
Crossref
Crossref
Tihong Shao, Xiaodong Shi, Shanpeng Yang, Wei Zhang, Xiaohu Li, Jingwei Shu, Shehabaldin Alqalyoobi, Amir A. Zeki, Patrick S. Leung & Zongwen Shuai. (2021) Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations. Frontiers in Immunology 12.
Crossref
Crossref
Iñaki Salvador-Corres, Bibiana Quirant-Sanchez, Aina Teniente-Serra, Carmen Centeno, Amalia Moreno, Laura Rodríguez-Pons, Pere Serra-Mitjá, Marian García-Nuñez, Eva Martinez-Caceres, Antoni Rosell, Alejandro Olivé & Karina Portillo. (2021) Detección de autoanticuerpos en el lavado broncoalveolar en pacientes con enfermedad pulmonar intersticial difusa. Archivos de Bronconeumología 57:5, pages 351-358.
Crossref
Crossref
Iñaki Salvador-Corres, Bibiana Quirant-Sanchez, Aina Teniente-Serra, Carmen Centeno, Amalia Moreno, Laura Rodríguez-Pons, Pere Serra-Mitjá, Marian García-Nuñez, Eva Martinez-Caceres, Antoni Rosell, Alejandro Olivé & Karina Portillo. (2021) Detection of autoantibodies in bronchoalveolar lavage in patients with diffuse interstitial lung disease. Archivos de Bronconeumología (English Edition) 57:5, pages 351-358.
Crossref
Crossref
Tamara Vojinovic, Ilaria Cavazzana, Paolo Ceruti, Micaela Fredi, Denise Modina, Marialma Berlendis & Franco Franceschini. (2020) Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis. Clinical Reviews in Allergy & Immunology 60:1, pages 87-94.
Crossref
Crossref
Adelle S. Jee, Matthew J.S. Parker, Jane F. Bleasel, Lauren K. Troy, Edmund M. Lau, Helen E. Jo, Alan K.Y. Teoh, Stephen Adelstein, Susanne Webster & Tamera J. Corte. (2021) Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration 100:9, pages 853-864.
Crossref
Crossref
Haralampos M. Moutsopoulos & Evangelia Zampeli. 2021. Immunology and Rheumatology in Questions. Immunology and Rheumatology in Questions
95
105
.
Kun Huang & Rohit Aggarwal. (2020) Antisynthetase syndrome: A distinct disease spectrum. Journal of Scleroderma and Related Disorders 5:3, pages 178-191.
Crossref
Crossref
Giulia Dei, Paola Rebora, Martina Catalano, Marco Sebastiani, Paola Faverio, Maria Rosa Pozzi, Andreina Manfredi, Paolo Cameli, Francesco Salton, Carlo Salvarani, Lorenzo Cavagna, Marco Confalonieri, Elena Bargagli, Fabrizio Luppi & Alberto Pesci. (2020) Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis. Journal of Clinical Medicine 9:9, pages 3033.
Crossref
Crossref
Joanna L. Marco & Bridget F. Collins. (2020) Clinical manifestations and treatment of antisynthetase syndrome. Best Practice & Research Clinical Rheumatology 34:4, pages 101503.
Crossref
Crossref
Sarah L Tansley, Zoe Betteridge, Hui Lu, Emma Davies, Simon Rothwell, Paul P New, Hector Chinoy, Patrick Gordon, Harsha Gunawardena, Mark Lloyd, Richard Stratton, Robert Cooper & Neil J McHugh. (2020) The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients. Rheumatology 59:7, pages 1626-1631.
Crossref
Crossref
Katsuaki Asakawa, Kazutaka Yoshizawa, Ami Aoki, Yosuke Kimura, Takahiro Tanaka, Kazumasa Ohashi, Masachika Hayashi, Toshiaki Kikuchi, Shinji Sato & Toshinori Takada. (2020) Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies. Clinical Rheumatology 39:7, pages 2171-2178.
Crossref
Crossref
Lauren J Green, Lorraine O’Neill & Charlotte J Frise. (2018) Antisynthetase syndrome in pregnancy: A case and review of the literature. Obstetric Medicine 13:2, pages 96-100.
Crossref
Crossref
Ting Zhang, Fangfang Yuan, Li Xu, Wenjia Sun, Lei Liu & Jing Xue. (2020) Characteristics of patients with primary Sjögren’s syndrome associated interstitial lung disease and relevant features of disease progression. Clinical Rheumatology 39:5, pages 1561-1568.
Crossref
Crossref
Yin Liu, Xiaoqing Liu, Miaomiao Xie, Zhiyong Chen, Jian He, Zhengge Wang, Jinghong Dai & Hourong Cai. (2020) Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review. Respiratory Medicine 165, pages 105920.
Crossref
Crossref
Ben Mulhearn, Sarah L. Tansley & Neil J. McHugh. (2020) Autoantibodies in connective tissue disease. Best Practice & Research Clinical Rheumatology 34:1, pages 101462.
Crossref
Crossref
Mengxue Tian, Wenhan Huang, Feifeng Ren, Lei Luo, Jun Zhou, Dongmei Huang & Lin Tang. (2019) Comparative analysis of connective tissue disease–associated interstitial lung disease and interstitial pneumonia with autoimmune features. Clinical Rheumatology 39:2, pages 575-583.
Crossref
Crossref
Baptiste Hervier & Yurdagül Uzunhan. (2020) Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment. Frontiers in Medicine 6.
Crossref
Crossref
A. Sclafani, K. M. D’Silva, B. P. Little, E. M. Miloslavsky, J. J. Locascio, A. Sharma & S. B. Montesi. (2019) Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody. Respiratory Research 20:1.
Crossref
Crossref
Michela Gasparotto, Mariele Gatto, Francesca Saccon, Anna Ghirardello, Luca Iaccarino & Andrea Doria. (2019) Pulmonary involvement in antisynthetase syndrome. Current Opinion in Rheumatology 31:6, pages 603-610.
Crossref
Crossref
Hui Liu, Sheng Xie, Tian Liang, Li Ma, Hongliang Sun, Huaping Dai & Chen Wang. (2019) Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome. European Radiology 29:10, pages 5349-5357.
Crossref
Crossref
Kathryn Long & Sonye K. Danoff. (2019) Interstitial Lung Disease in Polymyositis and Dermatomyositis. Clinics in Chest Medicine 40:3, pages 561-572.
Crossref
Crossref
Sara Sabbagh, Iago Pinal-Fernandez, Takayuki Kishi, Ira N Targoff, Frederick W Miller, Lisa G Rider & Andrew Lee Mammen. (2019) Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Annals of the Rheumatic Diseases 78:7, pages 988-995.
Crossref
Crossref
Z. Betteridge, S. Tansley, G. Shaddick, H. Chinoy, R.G. Cooper, R.P. New, J.B. Lilleker, J. Vencovsky, L. Chazarain, K. Danko, M. Nagy-Vincze, L. Bodoki, M. Dastmalchi, L. Ekholm, I.E. Lundberg & N. McHugh. (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. Journal of Autoimmunity 101, pages 48-55.
Crossref
Crossref
Jumpei Temmoku, Shuzo Sato, Yuya Fujita, Tomoyuki Asano, Eiji Suzuki, Takashi Kanno, Makiko Yashiro Furuya, Naoki Matsuoka, Hiroko Kobayashi, Hiroshi Watanabe, Tomohiro KogaToshimasa ShimizuAtsushi KawakamiKiyoshi Migita. (2019) Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis. Medicine 98:20, pages e15578.
Crossref
Crossref
John B. Miller, Sonye K. Danoff, Clifton O. BinghamIIIIII, Julie J. Paik, Christopher A. Mecoli, Eleni Tiniakou, Lisa Christopher-Stine & Jemima Albayda. (2019) Sonographic findings from inflammatory arthritis due to antisynthetase syndrome. Clinical Rheumatology 38:5, pages 1477-1483.
Crossref
Crossref
Courtney L. Shappley, Julie J. Paik & Lesley Ann Saketkoo. (2019) Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications. Current Treatment Options in Rheumatology 5:1, pages 56-83.
Crossref
Crossref
M. Mahmud, U. Schnoor & O. M. Steinmetz. (2018) Progrediente Luftnot und Schwäche bei einer 61-jährigen PatientinProgressive respiratory failure and weakness in a 61-year-old woman. Der Internist 60:2, pages 186-192.
Crossref
Crossref
Robert W. Hallowell & Sonye K. Danoff. (2018) Treatment of Interstitial Lung Disease Associated With Myositis and the Anti-Synthetase Syndrome. Current Treatment Options in Rheumatology 4:4, pages 316-328.
Crossref
Crossref
Katalin Szabó, Levente Bodoki, Melinda Nagy-Vincze, Anett Vincze, Erika Zilahi, Peter Szodoray, Katalin Dankó & Zoltán Griger. (2018) Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
Ausilia Sellitto, Luigi Elio Adinolfi, Ciro Romano, Francesco Iovino, Pasquale Pio Auriemma, Daniela Russo & Ferdinando de Vita. (2018) Plantar Kaposi Sarcoma Revealed by Antisynthetase Syndrome. JCR: Journal of Clinical Rheumatology 24:5, pages 281-285.
Crossref
Crossref
Neil J. McHugh & Sarah L. Tansley. (2018) Autoantibodies in myositis. Nature Reviews Rheumatology 14:5, pages 290-302.
Crossref
Crossref
Christopher A. Mecoli & Lisa Christopher-Stine. (2018) Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. Current Rheumatology Reports 20:5.
Crossref
Crossref
Danielle Antin-Ozerkis, Ami Rubinowitz, Janine Evans, Robert J. Homer & Richard A. Matthay. 2018. Interstitial Lung Disease. Interstitial Lung Disease
157
185
.
Giacomo Grasselli, Beatrice Vergnano, Maria Rosa Pozzi, Vittoria Sala, Gabriele D’Andrea, Vittorio Scaravilli, Marco Mantero, Alberto Pesci & Antonio Pesenti. (2017) Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?. Annals of Intensive Care 7:1.
Crossref
Crossref
Helena Andersson, Eva Kirkhus, Torhild Garen, Ragnhild Walle-Hansen, Else Merckoll & Øyvind Molberg. (2017) Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Niharika Sharma, Michael S. Putman, Rekha Vij, Mary E. Strek & Anisha Dua. (2017) Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. The Journal of Rheumatology 44:11, pages 1612-1618.
Crossref
Crossref
Walter Alberto Sifuentes-Giraldo, María Jesús García-Villanueva & Luis Gorospe. (2017) Spontaneous pneumomediastinum complicating interstitial lung disease, associated with clinically amyopathic dermatomyositis and positive anti-MDA5 antibodies. Revista Colombiana de Reumatología (English Edition) 24:4, pages 259-264.
Crossref
Crossref
Walter Alberto Sifuentes-Giraldo, María Jesús García-Villanueva & Luis Gorospe. (2017) Neumomediastino espontáneo como complicación de enfermedad pulmonar intersticial, asociada con dermatomiositis clínicamente amiopática y anticuerpos anti-MDA5 positivos. Revista Colombiana de Reumatología 24:4, pages 259-264.
Crossref
Crossref
Christopher A. MecoliArash H. LahoutiRobert A. BrodskyAndrew L. MammenLisa Christopher-Stine. (2017) High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies. Neurology Neuroimmunology & Neuroinflammation 4:5.
Crossref
Crossref
Adrian Y. S. Lee. (2017) A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity. Rheumatology International 37:8, pages 1323-1333.
Crossref
Crossref
Jingli Shi, Shanshan Li, Hanbo Yang, Yamei Zhang, Qinglin Peng, Xin Lu & Guochun Wang. (2017) Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies. The Journal of Rheumatology 44:7, pages 1051-1057.
Crossref
Crossref
G. Boleto, J.-M. Perotin, J.-P. Eschard & J.-H. Salmon. (2017) Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature. Rheumatology International 37:7, pages 1203-1206.
Crossref
Crossref
Adelle Jee, Stephen Adelstein, Jane Bleasel, Gregory Keir, MaiAnh Nguyen, Joanne Sahhar, Peter Youssef & Tamera Corte. (2017) Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine 6:5, pages 51.
Crossref
Crossref
A.C. Pinheiro, E.K.A.F. Queiroz, A.B. Galindo, C.L.O. Martins, D.L.A. Silva & F.C.O. Farias. (2017) DOENÇA PULMONAR INTERSTICIAL COMO MANIFESTAÇÃO DA SÍNDROME ANTISSINTETASE. Revista Brasileira de Reumatologia 57, pages S219.
Crossref
Crossref
Teck Choon Tan, Louise Wienholt & Stephen Adelstein. (2016) TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia. International Journal of Rheumatic Diseases 19:10, pages 996-1001.
Crossref
Crossref
Ernesto Trallero-Araguás, Josep María Grau-Junyent, Anne Labirua-Iturburu, Francisco José García-Hernández, Manuel Monteagudo-Jiménez, Guadalupe Fraile-Rodriguez, Iñigo Les-Bujanda, Mónica Rodriguez-Carballeira, Luis Sáez-Comet & Albert Selva-O’Callaghan. (2016) Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Seminars in Arthritis and Rheumatism 46:2, pages 225-231.
Crossref
Crossref
Seung Taek Song, Song Soo Kim, Ji Young Kim, So Young Lee, Kwangwoo Kim, In Sun Kwon, Ji Na Kim, Won Hong Park, In Seol Yoo, Su-Jin Yoo, Jin Hyun Kim, Seong Wook Kang & Seung-Cheol Shim. (2016) Association of Single Nucleotide Polymorphisms of PADI4 and HLA-DRB1 Alleles with Susceptibility to Rheumatoid Arthritis-Related Lung Diseases. Lung 194:5, pages 745-753.
Crossref
Crossref
Leah J. Witt, James J. Curran & Mary E. Strek. (2016) The Diagnosis and Treatment of Antisynthetase Syndrome. Clinical Pulmonary Medicine 23:5, pages 218-226.
Crossref
Crossref
Ana C. Zamora, Sumedh S. Hoskote, Beatriz Abascal-Bolado, Darin White, Christian W. Cox, Jay H. Ryu & Teng Moua. (2016) Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respiratory Medicine 118, pages 39-45.
Crossref
Crossref
Jutta Bauhammer, Norbert Blank, Regina Max, Hanns-Martin Lorenz, Ulrich Wagner, Dietmar Krause & Christoph Fiehn. (2016) Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response. The Journal of Rheumatology 43:8, pages 1566-1574.
Crossref
Crossref
Caramaschi Paola, Festi Giuliana, Orsolini Giovanni, Caimmi Cristian & Biasi Domenico. (2016) Dramatic improvement of anti-SS-A/Ro-associated interstitial lung disease after immunosuppressive treatment. Rheumatology International 36:7, pages 1015-1021.
Crossref
Crossref
Helena Andersson, Trond Mogens Aaløkken, Anne Günther, Georg Karl Mynarek, Torhild Garen, May Brit Lund & Øyvind Molberg. (2016) Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study. The Journal of Rheumatology 43:6, pages 1107-1113.
Crossref
Crossref
T.K. Jain, R.K. Basher, A. Bhattacharya, B.R. Mittal, J. Shukla & M. Prakash. (2016) 18 F-FDG PET/CT in diagnosis and response evaluation in an unusual case of antisynthetase syndrome presenting as pyrexia of unknown origin. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 35:3, pages 197-199.
Crossref
Crossref
T.K. Jain, R.K. Basher, A. Bhattacharya, B.R. Mittal, J. Shukla & M. Prakash. (2016) 18F-FDG PET/CT in diagnosis and response evaluation in an unusual case of antisynthetase syndrome presenting as pyrexia of unknown origin. Revista Española de Medicina Nuclear e Imagen Molecular 35:3, pages 197-199.
Crossref
Crossref
Thomas Bahmer, Micaela Romagnoli, Francesco Girelli, Martin Claussen & Klaus F. Rabe. (2016) The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist. Respiratory Medicine 113, pages 80-92.
Crossref
Crossref
Osama Dasa, Mohammed Ruzieh & Omar Oraibi. (2016) Successful Treatment of Life-Threatening Interstitial Lung Disease Secondary to Antisynthetase Syndrome Using Rituximab. American Journal of Therapeutics 23:2, pages e639-e645.
Crossref
Crossref
Koralia E. Paschalaki, Joseph Jacob & Athol U. Wells. (2016) Monitoring of Lung Involvement in Rheumatologic Disease. Respiration 91:2, pages 89-98.
Crossref
Crossref
Kelsey Guerreso & Edward Alexander Conner. (2016) Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension. Respiratory Medicine Case Reports 17, pages 47-49.
Crossref
Crossref
Bolanle A. Omotoso, Melissa I. Ogden & Rasheed A. Balogun. (2015) Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease. Journal of Clinical Apheresis 30:6, pages 375-379.
Crossref
Crossref
Lívia Regina Theilacker, Fabíola Sampaio Brandão, Fernanda Velloso Goulart, João Luiz Pereira Vaz, Luiz Octávio Dias D’Almeida & Maria Cecília da Fonseca Salgado. (2015) Antisynthetase Syndrome: two case reports and literature review. Revista Brasileira de Reumatologia (English Edition) 55:2, pages 177-180.
Crossref
Crossref
Lívia Regina Theilacker, Fabíola Sampaio Brandão, Fernanda Velloso Goulart, João Luiz Pereira Vaz, Luiz Octávio Dias D’Almeida & Maria Cecília da Fonseca Salgado. (2015) Síndrome Antissintetase: relato de dois casos e revisão da literatura. Revista Brasileira de Reumatologia 55:2, pages 177-180.
Crossref
Crossref
Ju Sun SongJiwon HwangHoon-Suk ChaByeong-Ho JeongGee Young SuhMan Pyo ChungEun-Suk Kang. (2015) Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease. Yonsei Medical Journal 56:3, pages 676.
Crossref
Crossref
Chester V. Oddis & Dana P. Ascherman. 2015. Rheumatology. Rheumatology
1224
1236
.
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, Zoe Betteridge, Lászlóné Szöllősi & Katalin Dankó. (2014) Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmunity Reviews 13:12, pages 1211-1219.
Crossref
Crossref
Sarah Tansley & Harsha Gunawardena. (2013) The Evolving Spectrum of Polymyositis and Dermatomyositis—Moving Towards Clinicoserological Syndromes: A Critical Review. Clinical Reviews in Allergy & Immunology 47:3, pages 264-273.
Crossref
Crossref
Sarah L. Tansley & Neil J. McHugh. (2014) Myositis Specific and Associated Autoantibodies in the Diagnosis and Management of Juvenile and Adult Idiopathic Inflammatory Myopathies. Current Rheumatology Reports 16:12.
Crossref
Crossref
B. Hervier & O. Benveniste. (2014) Phénotypes cliniques et pronostic du syndrome des antisynthétases. La Revue de Médecine Interne 35:7, pages 453-460.
Crossref
Crossref
Luigi Cinquanta & Renato Tozzoli. (2014) Gli autoanticorpi nelle sindromi overlap reumatiche autoimmuniAutoantibodies in autoimmune rheumatic overlap syndromes. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 10:1, pages 6-14.
Crossref
Crossref
Moises Labrador-Horrillo, Maria Angeles Martinez, Albert Selva-O'Callaghan, Ernesto Trallero-Araguas, Eva Balada, Miquel Vilardell-Tarres & Cándido Juárez. (2014) Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis. Journal of Immunology Research 2014, pages 1-8.
Crossref
Crossref
Rohit Aggarwal, Vivek Nagaraja & Dinesh Khanna. 2014. Drugs Targeting B-Cells in Autoimmune Diseases. Drugs Targeting B-Cells in Autoimmune Diseases
153
180
.
Patrick D. W. Kiely & Felix Chua. (2013) Interstitial Lung Disease in Inflammatory Myopathies: Clinical Phenotypes and Prognosis. Current Rheumatology Reports 15:9.
Crossref
Crossref
Baptiste Hervier & Olivier Benveniste. (2013) Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome. Current Rheumatology Reports 15:8.
Crossref
Crossref
Marcela Gran Pina Cruellas, Vilma dos Santos Trindade Viana, Maurício Levy-Neto, Fernando Henrique Carlos de Souza & Samuel Katsuyuki Shinjo. (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics 68:7, pages 909-914.
Crossref
Crossref
Aurora Menéndez, Jesús Gómez, Luis Caminal-Montero, José Bernardino Díaz-López, Iván Cabezas-Rodríguez & Lourdes Mozo. (2013) Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus. The Scientific World Journal 2013, pages 1-8.
Crossref
Crossref
Xiaomin Cen, Chuan Zuo, Min Yang, Geng Yin & Qibing Xie. (2013) A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathy. Clinical and Developmental Immunology 2013, pages 1-4.
Crossref
Crossref
O. Palm, T. Garen, T. Berge Enger, J. L. Jensen, M.-B. Lund, T. M. Aalokken & J. T. Gran. (2012) Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data. Rheumatology 52:1, pages 173-179.
Crossref
Crossref
Luca Iaccarino, Mariele Gatto, Silvano Bettio, Francesco Caso, Mariaelisa Rampudda, Margherita Zen, Anna Ghirardello, Leonardo Punzi & Andrea Doria. (2013) Overlap connective tissue disease syndromes. Autoimmunity Reviews 12:3, pages 363-373.
Crossref
Crossref
Baptiste Hervier, Hervé Devilliers, Raluca Stanciu, Alain Meyer, Yurdagul Uzunhan, Agathe Masseau, Sylvain Dubucquoi, Pierre-Yves Hatron, Lucile Musset, Benoit Wallaert, Hilario Nunes, Thierry Maisonobe, Nils-Olivier Olsson, Daniel Adoue, Philippe Arlet, Jean Sibilia, Marguerite Guiguet, Dominique Lauque, Zahir Amoura, Eric Hachulla, Mohamed Hamidou & Olivier Benveniste. (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmunity Reviews 12:2, pages 210-217.
Crossref
Crossref
Lisa Christopher-Stine, Dwight R. Robinson, Carol C. Wu & Eugene J. Mark. (2012) Case 37-2012. New England Journal of Medicine 367:22, pages 2134-2146.
Crossref
Crossref
RALUCA STANCIU, MARGUERITE GUIGUET, LUCILE MUSSET, DIANE TOUITOU, CATHERINE BEIGELMAN, AUDE RIGOLET, NATHALIE COSTEDOAT-CHALUMEAU, YVES ALLENBACH, BAPTISTE HERVIER, ODILE DUBOURG, THIERRY MAISONOBE, JEAN-LUC CHARUEL, ANTHONY BEHIN, SERGE HERSON, ZAHIR AMOURA, PHILIPPE GRENIER & OLIVIER BENVENISTE. (2012) Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use. The Journal of Rheumatology 39:9, pages 1835-1839.
Crossref
Crossref
Spyridon A. Papiris, Konstantinos Kagouridis & Demosthenes Bouros. (2012) Serologic evaluation in idiopathic interstitial pneumonias. Current Opinion in Pulmonary Medicine 18:5, pages 433-440.
Crossref
Crossref
Isabelle Marie, Pierre Yves Hatron, Stéphane Dominique, Patrick Cherin, Luc Mouthon, Jean-François Menard, Hervé Levesque & Fabienne Jouen. (2012) Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody. Seminars in Arthritis and Rheumatism 41:6, pages 890-899.
Crossref
Crossref
Tsuneyo Mimori, Ran Nakashima & Yuji Hosono. (2012) Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment. Current Rheumatology Reports 14:3, pages 264-274.
Crossref
Crossref
João Pedro Ferreira, Isabel Almeida, António Marinho, Conceição Cerveira & Carlos Vasconcelos. (2012) Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma. ISRN Rheumatology 2012, pages 1-4.
Crossref
Crossref
V. Limaye, P. Hissaria, C.-L. Liew & B. Koszyka. (2012) Efficacy of rituximab in refractory antisynthetase syndrome. Internal Medicine Journal 42:3, pages e4-e7.
Crossref
Crossref
Danielle Antin-Ozerkis, Ami Rubinowitz, Janine Evans, Robert J. Homer & Richard A. Matthay. (2012) Interstitial Lung Disease in the Connective Tissue Diseases. Clinics in Chest Medicine 33:1, pages 123-149.
Crossref
Crossref
Francesca Ingegnoli, Chiara Lubatti, Anna Ingegnoli, Patrizia Boracchi, Silvana Zeni & Pier Luigi Meroni. (2012) Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature. Autoimmunity Reviews 11:5, pages 335-340.
Crossref
Crossref
C. Dieval, E. Ribeiro, P. Mercié, P. Blanco, P. Duffau & M. Longy-Boursier. (2012) Le syndrome des antisynthétases : étude rétrospective à propos d’une série de 14 patients. La Revue de Médecine Interne 33:2, pages 76-79.
Crossref
Crossref
Ryusuke Yoshimi, Atsuhisa Ueda, Keiko Ozato & Yoshiaki Ishigatsubo. (2012) Clinical and Pathological Roles of Ro/SSA Autoantibody System. Clinical and Developmental Immunology 2012, pages 1-12.
Crossref
Crossref
J.-F. Boitiaux, M.-P. Debray, P. Nicaise-Roland, H. Adle-Biassette, C. Danel, C. Clerici, M. Aubier, X. Mariette, J. Cadranel & B. Crestani. (2011) Idiopathic interstitial lung disease with anti-SSA antibody. Rheumatology 50:12, pages 2245-2250.
Crossref
Crossref
Kizuku Watanabe, Tomohiro Handa, Kiminobu Tanizawa, Yuji Hosono, Yoshio Taguchi, Satoshi Noma, Yoichiro Kobashi, Takeshi Kubo, Kensaku Aihara, Kazuo Chin, Sonoko Nagai, Tsuneyo Mimori & Michiaki Mishima. (2011) Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respiratory Medicine 105:8, pages 1238-1247.
Crossref
Crossref
P. Ghillani, C. André, C. Toly, A.M. Rouquette, D. Bengoufa, P. Nicaise, C. Goulvestre, A. Gleizes, M.A. Dragon-Durey, M.A. Alyanakian, P. Chretien, S. Chollet-Martin, L. Musset, B. Weill & C. Johanet. (2011) Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study. Autoimmunity Reviews 10:9, pages 509-513.
Crossref
Crossref
Ane Labirua-Iturburu, Ernesto Trallero Araguás & Albert Selva O’Callaghan. (2011) Síndrome por anticuerpos antisintetasa. Medicina Clínica 137:2, pages 77-83.
Crossref
Crossref
Elena Katzap, Maria-Louise Barilla-LaBarca & Galina Marder. (2011) Antisynthetase Syndrome. Current Rheumatology Reports 13:3, pages 175-181.
Crossref
Crossref
Chester V. Oddis & Dana P. Ascherman. 2011. Rheumatology. Rheumatology
1439
1455.e4
.
Ane Labirua & Ingrid E Lundberg. (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Current Opinion in Rheumatology 22:6, pages 633-638.
Crossref
Crossref
Ran Nakashima & Tsuneyo Mimori. (2010) Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. International Journal of Clinical Rheumatology 5:5, pages 523-536.
Crossref
Crossref
Meena Kalluri & Chester V. Oddis. (2010) Pulmonary Manifestations of the Idiopathic Inflammatory Myopathies. Clinics in Chest Medicine 31:3, pages 501-512.
Crossref
Crossref
Yong Min JoJin Kyu JungYong Jun KimSang Yeob LeeSung Won LeeWon Tae Chung. (2010) A Case of Rituximab Treatment for Interstitial Lung Disease in a Patient with Antisynthetase Syndrome. The Journal of the Korean Rheumatism Association 17:4, pages 448.
Crossref
Crossref
David M Hansell, David A Lynch, H Page McAdams & Alexander A Bankier. 2010. Imaging of Diseases of the Chest. Imaging of Diseases of the Chest
561
639
.
Aryeh Fischer, Jeffrey J. Swigris, Roland M. du Bois, David A. Lynch, Gregory P. Downey, Gregory P. Cosgrove, Stephen K. Frankel, Evans R. Fernandez-Perez, JoAnn Z. Gillis & Kevin K. Brown. (2009) Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respiratory Medicine 103:11, pages 1719-1724.
Crossref
Crossref
E. Vandenbroucke, J. C. Grutters, J. Altenburg, W. G. Boersma, E. J. ter Borg & J. M. M. van den Bosch. (2009) Rituximab in life threatening antisynthetase syndrome. Rheumatology International 29:12, pages 1499-1502.
Crossref
Crossref
Linda M. Mileti, Mary E. Strek, Timothy B. Niewold, James J. Curran & Nadera J. Sweiss. (2009) Clinical Characteristics of Patients With Anti-Jo-1 Antibodies. JCR: Journal of Clinical Rheumatology 15:5, pages 254-255.
Crossref
Crossref
B. Hervier, M. Rimbert, F. Colonna, M. A. Hamidou & M. Audrain. (2009) Clinical significance of anti-Ro/SSA-52 kDa antibodies--a retrospective monocentric study. Rheumatology 48:8, pages 964-967.
Crossref
Crossref
Meena Kalluri, Steven A. Sahn, Chester V. Oddis, Suzanne L. Gharib, Lisa Christopher-Stine, Sonye K. Danoff, Livia Casciola-Rosen, Grace Hong, Paul F. Dellaripa & Kristin B. Highland. (2009) Clinical Profile of Anti-PL-12 Autoantibody. Chest 135:6, pages 1550-1556.
Crossref
Crossref
Andrea Váncsa, I. Csípő, J. Németh, K. Dévényi, L. Gergely & K. Dankó. (2009) Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients. Rheumatology International 29:9, pages 989-994.
Crossref
Crossref
Adam S. Morgenthau & Maria L. Padilla. (2009) Spectrum of Fibrosing Diffuse Parenchymal Lung Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:1, pages 2-23.
Crossref
Crossref
. (2007) Current World Literature. Current Opinion in Rheumatology 19:6, pages 651-659.
Crossref
Crossref
Enrique Júdez Navarro, Myriam Martínez Carretero & Gonzalo Fidel Martínez Jiménez. (2007) Síndrome antisintetasa sin afectación muscular. Reumatología Clínica 3:6, pages 276-277.
Crossref
Crossref
Inmaculada Macías Fernández, José Javier Pérez Venegas & Sergio García Pérez. (2007) Síndrome antisintetasa. Seminarios de la Fundación Española de Reumatología 8:1, pages 28-33.
Crossref
Crossref
. (2007) Current World Literature. Current Opinion in Rheumatology 19:1, pages 81-89.
Crossref
Crossref
Enrique Júdez Navarro, Myriam Martínez Carretero & Gonzalo Fidel Martínez Jiménez. (2007) Antisynthetase Syndrome Without Muscle Involvement. Reumatología Clínica (English Edition) 3:6, pages 276-277.
Crossref
Crossref